Fundraising Fox퓨젠바이오
1 known investors
Find your way into 퓨젠바이오
Sign up to see every warm intro you have to 퓨젠바이오
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 퓨젠바이오 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fugen Bio (퓨젠바이오) develops patented biomaterials, notably its CLEPS® ingredient, and sells consumer health and beauty products such as the Cellab biogenic essence and Cellna, a blood-sugar and insulin-resistance care product with clinically tested effects. The company operates in the biotech-based cosmetics and health supplement space, primarily in South Korea.
Investors · 1
Frequently asked questions
- What does 퓨젠바이오 do?
- Fugen Bio (퓨젠바이오) develops patented biomaterials, notably its CLEPS® ingredient, and sells consumer health and beauty products such as the Cellab biogenic essence and Cellna, a blood-sugar and insulin-resistance care product with clinically tested effects. The company operates in the biotech-based cosmetics and health supplement space, primarily in South Korea.
- Who are 퓨젠바이오's investors?
- 퓨젠바이오's investors include Solidus Investment.